Literature DB >> 31678294

Eosinophilic bronchiolitis successfully treated with mepolizumab.

Yuichiro Takeshita1, Seiichi Nobuyama2, Yukiko Kanetsuna3, Akihiko Tanaka4, Mitsuru Adachi5, Tetsuo Sato1, Yuji Tada6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31678294     DOI： 10.1016/j.jaip.2019.10.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  3 in total

1.  Case Report: Eosinophilic Bronchiolitis With Eosinophil ETosis in Mucus Plugs Successfully Treated With Benralizumab.

Authors:  Hisashi Sasaki; Jun Miyata; Akiko Irie; Ayako Kuwata; Yuji Kouzaki; Shigeharu Ueki; Akihiko Kawana
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

Review 2.  Current and emerging biologic therapies targeting eosinophilic disorders.

Authors:  Mitchell M Pitlick; James T Li; Thanai Pongdee
Journal:  World Allergy Organ J       Date:  2022-07-31       Impact factor: 5.516

3.  Benralizumab use in chronic eosinophilic pneumonia with eosinophilic bronchiolitis and chronic airway infection.

Authors:  Tomotsugu Takano; Yuh Inutsuka; Satoshi Nakamura; Nobuhisa Ando; Masashi Komori
Journal:  Respirol Case Rep       Date:  2021-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.